RecruitingNCT06675383

SCREENING AFTER STROKE - ATRIAL FIBRILLATION

SCREENING AFTER STROKE - ATRIAL FIBRILLATION - the SIGNIFICANCE of TIMING and CHOICE of DEVICE


Sponsor

Vestre Viken Hospital Trust

Enrollment

410 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

As much as 20-30% of all strokes are attributed to atrial fibrillation (AF), making the detection of AF highly important, as AF-related strokes are largely preventable with optimal treatment. Therefore, most guidelines recommend screening patients for AF after a stroke, although the optimal timing and choice of monitoring device for screening remain undefined. Our aim is to investigate whether AF screening as early as possible after stroke symptom onset provides a higher detection rate compared to screening after discharge. Additionally, we aim to determine if a 3-lead ECG device provides a higher detection rate compared to a 1-lead patch recorder.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • years or older
  • Ischemic stroke
  • Without known AF or those with previously diagnosed paroxysmal AF exhibiting sinus rhythm upon admission

Exclusion Criteria3

  • AF at hosptial admission
  • Unable or unwilling to provide informed consent
  • A life expectancy of less than one year

Locations(1)

Vestre Viken Hospital trust, Baerum Hospital

Sogneprest Munthe-kaas Vei 100, Gjettum, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06675383


Related Trials